0
0
Madhya Pradesh Governor Mangubhai Patel has called on elected representatives, including MLAs and MPs, to take an active role alongside financial support to eliminate sickle cell anaemia in the state’s tribal regions. Speaking at a health programme review meeting at Raj Bhavan in Bhopal on September 10, 2025, he highlighted the significance of ongoing efforts and urged for their expansion and deeper engagement among local leaders.
The meeting reviewed key public health initiatives targeting sickle cell disease (SCD), a genetic disorder prevalent in tribal populations. Governor Patel noted the successful completion of a 100-day sickle cell testing campaign, which distributed more than 12 lakh genetic status cards to individuals affected or at risk. He proposed extending this campaign by an additional 125 days to deepen community outreach, especially through screening camps integrated into weekly markets to reach underserved groups.
Notably, Governor Patel emphasized the importance of continuous involvement of frontline health workers with Anganwadi centres—government-run child and maternal nutrition and health hubs—citing these centres as vital for scaling up family welfare programmes including sickle cell screening and treatment. He also called for rigorous monitoring of multiple health programmes such as PM JANMAN, Dharti Abhiyan, and tuberculosis management during district visits.
In addition to biomedical measures, the Governor advocated for improving access to Ayurvedic treatment for sickle cell patients, citing pilot projects that have already provided Ayurvedic medicines to patients in Dhar and Barwani districts. This layered approach aims to address sickle cell disease comprehensively through prevention, screening, medical care, and traditional medicine.
Context and Public Health Significance
Sickle cell anaemia is a hereditary blood disorder characterized by abnormally shaped red blood cells that impair oxygen transport. It disproportionately affects tribal populations in India, including many in Madhya Pradesh. According to the Ministry of Health and Family Welfare’s National Sickle Cell Anaemia Elimination Mission launched in 2023, approximately 6 crore people have undergone screening across 17 tribal-dominated states. Identified cases require lifelong management to reduce complications such as anemia, pain crises, infections, and early mortality.
Experts estimate that in India, around 120,000 to 150,000 individuals live with sickle cell disease, with many cases going undiagnosed due to limited awareness and healthcare access. The disease often leads to serious health consequences, including higher mortality rates in children and pregnant women if untreated. Studies show that without proper management, 20% of patients may die within two years of diagnosis and many do not survive into adulthood.
Governor Patel’s call aligns with India’s broader public health vision to eliminate sickle cell disease by 2047 through the National Mission, which combines genetic screening, counselling, treatment, and community engagement. Distribution of genetic status cards aims to inform individuals of their carrier status and prevent transmission through informed reproductive choices. Screening camps embedded in community settings and leveraging government health workers are critical strategies.
Expert Opinions and Challenges
Dr. Saloni Sidana, MP National Health Mission director, described the state’s approach as innovative, integrating compulsory antenatal screening for sickle cell disease with protocols for managing affected pregnancies. “This is essential because sickle cell disease contributes significantly to maternal and neonatal mortality,” she said. The establishment of specialized centers for prenatal genetic testing and treatment in Madhya Pradesh further reflects this commitment.
However, experts urge cautious optimism. Dr. Rajesh Kumar, a hematologist not involved in the state mission, highlights the complexities of implementing wide-scale genetic programs in resource-limited settings. “Screening and counselling are foundational but must be coupled with sustainable access to treatments such as Hydroxyurea, pain management, and comprehensive care delivery,” he explained. “Also, social stigma and misinformation remain barriers.”
Public health researchers stress the role of elected representatives in advocacy, resource mobilization, and policy leadership to overcome these challenges. Increasingly, MLAs and MPs with medical backgrounds or strong community ties have proven influential in transforming health behaviors and improving healthcare infrastructure in rural areas.
Implications for Daily Health Decisions
For individuals, particularly in tribal and high-prevalence areas, awareness of sickle cell carrier status and genetic counselling before marriage can significantly reduce disease transmission to offspring. Routine screening during pregnancy and early diagnosis improve maternal and child health outcomes. Ongoing management with medical therapies and lifestyle adaptations can extend life expectancy and enhance quality of life for affected patients.
The combined biomedical and traditional approach promoted by Madhya Pradesh’s government underscores a culturally sensitive model recognizing both modern medicine and Ayurveda. Public engagement and education remain critical, as do strengthening health systems to deliver regular follow-up care, medication, and emergency services.
Limitations and Future Directions
While the recent campaign achievements are encouraging, sustainable elimination of sickle cell disease requires long-term, multi-sectoral collaboration. Challenges include ensuring consistent funding, expanding comprehensive care centers, addressing rural healthcare access gaps, and combating stigma. The effectiveness of integrating Ayurvedic treatments into standard care needs continued evaluation.
The mission’s success also hinges on the active roles played by elected leaders, community health workers, families, and affected individuals in fostering awareness, supporting screening programs, and facilitating access to treatment.
Medical Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.
References
